Provisional Consent to the Distribution of a New Medicine Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Lamivudine 150 mg Tablet Glaxo Operations UK Limited, Ware, Hertfordshire, United Kingdom 3TC Lamivudine 10 mg/mL in 240 mL Oral solution Glaxo Operations UK Limited, Speke, Liverpool, United Kingdom 3TC Saquinavir mesylate 228.7 mg equivalent to 200 mg saquinavir free base Capsule F Hoffmann-La Roche Limited, Basle, Switzerland Invirase Note: These provisional consents are valid for 2 years from the date of publication of this notice. Dated this 30th day of May 1996. HUGH BABER, Assistant General Manager, Health Regulation and Protection, pursuant to delegation given by the Minister of Health on the 18th day of January 1996.